|
US2017252365A1
|
|
Immunomodulating compositions and methods of use thereof
|
|
WO2016115463A1
|
|
Inhibitors of phosphoglycerate dehydrogenase (phgdh) and uses thereof
|
|
WO2016040824A2
|
|
METHODS OF IDENTIFYING MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USE OF SAME TO MODULATE mTORC1
|
|
WO2016025533A2
|
|
Compositions and methods for treating synucleinopathies
|
|
US2016053304A1
|
|
Methods Of Depleting Target Sequences Using CRISPR
|
|
US2016053272A1
|
|
Methods Of Modifying A Sequence Using CRISPR
|
|
WO2015196072A2
|
|
Uses of kinase inhibitors for inducing and maintaining pluripotency
|
|
WO2015157772A1
|
|
Hsf1 in tumor stroma
|
|
US2015337376A1
|
|
Core Transcriptional Circuitry in Human Cells and Methods of Use Thereof
|
|
WO2015143072A1
|
|
Methods for inhibiting proliferation of cancer cells and uses thereof
|
|
WO2015127365A2
|
|
Calcium-independent sortase a mutants
|
|
WO2015073746A2
|
|
18f labeling of proteins using sortases
|
|
WO2015061607A1
|
|
Mtorc1 modulation by amino acids and uses thereof
|
|
US2015065556A1
|
|
Therapeutic targets for mitochondrial disorders
|
|
WO2014183071A2
|
|
In vitro production of red blood cells with sortaggable proteins
|
|
WO2014172470A2
|
|
Methods of mutating, modifying or modulating nucleic acid in a cell or nonhuman mammal
|
|
CA2906194A1
|
|
Benzimidazole derivatives and uses thereof
|
|
EP2971056A2
|
|
Cellular discovery platform for neurodegenerative diseases
|
|
US2014348749A1
|
|
Identification and treatment of tumors sensitive to glucose limitation
|
|
WO2014074805A1
|
|
Selective targeting of cancer stem cells
|
